首页 > 市场调查报告书 > 医疗设备

体外诊断

市场调查报告书

商品编码

1471869

全球产前检测市场

Global Prenatal Testing Market

出版日期: 2024年04月24日 | 出版商:

BCC Research | 英文 134 Pages | 订单完成后即时交付

价格

简介目录图表

全球产前检测市场规模预计将从 2023 年的 109 亿美元成长到 2028 年底的198 亿美元，预测期内复合年增长率为 12.6%。

按产品类型划分，消耗品产业预计将从2023年的63亿美元成长到2028年终的118亿美元，同期复合年增长率为13.4%。设备业预计将从2023年的46亿美元成长到2028年终的80亿美元，复合年增长率为11.6%。

本报告调查了全球产前检测市场，并提供了市场概况、法律制度、市场影响因素和市场机会分析、市场规模趋势和预测、各个细分市场和地区的详细分析、竞争格局，我们编制了主要企业。

产前检测市场影响因素
市场驱动因素
唐氏症的增加
罕见遗传疾病增加
生育年龄增加
技术进步
抑制因素
检验成本高
假阳性和假阴性结果
未来的机会
扩充应用
新兴市场
个人化医疗
任务
监管障碍
大众认知
非侵入性产前检测覆盖率挑战：政策失衡

第四章市场中的新兴与未来技术

透过全基因测序增强拷贝数变异检测
单核苷酸多态性分析
全EXOME定序
先进的成像技术
用于癌症检测的液态生物检体
人工智慧在产前检测的应用

第五章市场分析：依不同细分市场

市场规模：依产品类型
消耗品
装置
市场区隔：依技术划分
概述
市场占有率
非侵入性技术
侵入性技术
市场区隔: 按应用
概述
市场占有率
神经管缺陷
唐氏症
罕见遗传疾病
其他的
市场区隔：按最终用户
概述
市场占有率
诊断实验室
医院
市场区隔: 区域
概述
北美洲
欧洲
亚太地区
其他地区

第六章竞争状况

併购/合作
产前检测製造商和服务供应商的市场占有率
专利审查/新进展
概述
专利分析：按年份

第七章 ESG发展

产前检测在产业中的永续性
BCC 的观点

第8章附录

调查方法
主要读者
简称
来源
公司简介
10X GENOMICS
AGILENT TECHNOLOGIES INC.
BGI
EUROFINS SCIENTIFIC
F. HOFFMANN-LA ROCHE LTD.
ILLUMINA INC.
LABORATORY CORPORATION OF AMERICA HOLDINGS
MEDICOVER GENETICS
NATERA INC.
QIAGEN
QUEST DIAGNOSTICS INC.
REVVITY INC.
THERMO FISHER SCIENTIFIC INC.
YOURGENE HEALTH

简介目录图表

Product Code: MDS103A

The global market for prenatal testing is expected to grow from $10.9 billion in 2023 and projected to reach $19.8 billion by the end of 2028, at a compound annual growth rate (CAGR) of 12.6% during the forecast period of 2023 to 2028.

The global market for consumables segment of prenatal testing is expected to grow from $6.3 billion in 2023 and projected to reach $11.8 billion by the end of 2028, at a CAGR of 13.4% during the forecast period of 2023 to 2028.

The global market for instruments segment of prenatal testing is expected to grow from $4.6 billion in 2023 and projected to reach $8.0 billion by the end of 2028, at a CAGR of 11.6% during the forecast period of 2023 to 2028.

Report Scope

The scope of the prenatal testing market is extensive and continually evolving, reflecting the dynamic landscape of technologies and methodologies employed to assess fetal health during pregnancy. Genetic testing plays a central role, encompassing a range of approaches from traditional invasive procedures, such as amniocentesis and chorionic villus sampling to modern noninvasive methods, such as noninvasive prenatal testing (NIPT). This market is characterized by its global reach, with varying levels of adoption and accessibility across different regions. The focus is predominantly on screening for genetic disorders, including chromosomal abnormalities and hereditary conditions. The rise of comprehensive testing strategies evaluating multiple biomarkers enhances diagnostic accuracy. The market is driven by increasing maternal age, heightened awareness of genetic disorders and technological advancements. Ongoing research and development (R&D) efforts continue to shape the scope of prenatal testing, with a strong emphasis on improving accuracy and accessibility and incorporating innovative diagnostic and screening procedures. It presents insights into current and future potential, drivers, challenges, opportunities, industry status, developments, market trends, geographical challenges and strategies (e.g., mergers, acquisitions, collaborations). The report informs all market players, potential entrants, government agencies and other interested parties. The report covers geographic regions in detail, so companies interested in expanding their geographic reach will also find this helpful study.

Report Includes

37 data tables and 52 additional tables
An overview of the current and future global markets for prenatal testing
Analyses of global market trends, with historical revenue data (sales figures) for 2021-2022, estimates for 2023, forecasts for 2024, and projected CAGRs through 2028
Estimates of the current market size and revenue growth prospects, along with a market share analysis by technology and product types, application, end users and region
Discussion of the market opportunities and challenges, ongoing R&D efforts and regulatory scenarios
A look at emerging technologies related to prenatal testing
Overview of the sustainability trends and ESG developments, with emphasis on consumer attitudes, companies' ESG rankings and their ESG practices
Insight into the competitive landscape, including company market shares, financials and revenues
Profiles of the leading players, including Illumina Inc., Laboratory Corporation of America Holdings, Thermo Fisher Scientific Inc., Natera Inc., and F. Hoffmann-La Roche Ltd.

Chapter 1 Executive Summary

Market Outlook
Scope of Report
Market Summary

Chapter 2 Market Overview

Prenatal Testing
History of Prenatal Testing
Most Common Chromosomal Abnormalities
Down Syndrome
Trisomy 13 and Trisomy 18
Sex Chromosome Differences
Neural Tube Defects
Noninvasive Techniques
Noninvasive Prenatal Test/Cell-Free DNA Screening
Maternal Serum Screening Test
Ultrasound Testing
Others
Invasive Techniques
Chorionic Villus Sampling
Amniocentesis

Chapter 3 Market Dynamics

Factors Affecting the Prenatal Testing Market
Market Drivers
Increase in Down Syndrome
Increase in Rare Genetic Disorders
Increasing Maternal Age
Advancements in Technology
Restraints
High Cost of Testing
False Positives and Negatives Results
Future Opportunities
Expanding Applications
Emerging Markets
Personalized Medicine
Challenges
Regulatory Hurdles
Public Perception
Noninvasive Prenatal Testing Coverage Challenges: Policy Disparities

Chapter 4 Emerging and Upcoming Technologies in the Market

Introduction
Enhancing Copy Number Variation Detection Through Whole-Genome Sequencing
Single Nucleotide Polymorphisms Analysis
Whole-Exome Sequencing
Advanced Imaging Techniques
Liquid Biopsy for Cancer Detection
Artificial Intelligence in Prenatal Testing

Chapter 5 Market Segmentation Analysis

Segmentation by Product Type
Market Size
Consumables
Instruments
Segmentation by Technology
Overview
Market Share
Noninvasive Techniques
Invasive Techniques
Segmentation by Application
Overview
Market Share
Neural Tube Defects
Down Syndrome
Rare Genetic Disorders
Others
Segmentation by End User
Overview
Market Share
Diagnostic Laboratories
Hospitals
Geographic Breakdown
Overview
North America
Europe
Asia-Pacific
Rest of the World

Chapter 6 Competitive Landscape

Mergers, Acquisitions and Collaborations
Prenatal Testing Manufacturers and Service Providers Market Shares
Patent Review and New Developments
Overview
Patent Analysis by Year

Chapter 7 ESG Development

Introduction
Sustainability of Prenatal Testing in Industry
BCC Research Viewpoint

Chapter 8 Appendix

Methodology
Intended Audience
Abbreviations
Sources
Company Profiles
10X GENOMICS
AGILENT TECHNOLOGIES INC.
BGI
EUROFINS SCIENTIFIC
F. HOFFMANN-LA ROCHE LTD.
ILLUMINA INC.
LABORATORY CORPORATION OF AMERICA HOLDINGS
MEDICOVER GENETICS
NATERA INC.
QIAGEN
QUEST DIAGNOSTICS INC.
REVVITY INC.
THERMO FISHER SCIENTIFIC INC.
YOURGENE HEALTH

简介目录图表

List of Tables

Summary Table : Global Prenatal Testing Market, by Product, Through 2028
Table 1 : Timeline of Technology Development of Prenatal Testing, 1956-2017
Table 2 : Chance for Down Syndrome, by Age
Table 3 : Price Per Prenatal Testing Strategy, 2021
Table 4 : Global Prenatal Testing Market, by Product, Through 2028
Table 5 : Global Consumables Products Market in Prenatal Testing, by Region, Through 2028
Table 6 : Global Instruments Products Market in Prenatal Testing, by Region, Through 2028
Table 7 : Global Prenatal Testing Market, by Technology, Through 2028
Table 8 : Global Noninvasive Techniques Market in Prenatal Testing, by Type, Through 2028
Table 9 : Global Noninvasive Prenatal Testing Market, by Region, Through 2028
Table 10 : Global Maternal Serum Screening Market, by Region, Through 2028
Table 11 : Global Ultrasound-Based Testing Market, by Region, Through 2028
Table 12 : Global Others Noninvasive Techniques Market, by Region, Through 2028
Table 13 : Global Invasive Techniques in Prenatal Testing Market, by Type, Through 2028
Table 14 : Global Amniocentesis Invasive Techniques Market, by Region, Through 2028
Table 15 : Global Chorionic Villus Sampling Invasive Techniques Market, by Region, Through 2028
Table 16 : Global Others Invasive Techniques Market, by Region, Through 2028
Table 17 : Global Prenatal Testing Market, by Application, Through 2028
Table 18 : Global Neural Tube Defects Market in Prenatal Testing, by Region, Through 2028
Table 19 : Global Down Syndrome Market in Prenatal Testing, by Region, Through 2028
Table 20 : Global Rare Genetic Disorders Market in Prenatal Testing, by Region, Through 2028
Table 21 : Global Other Application Market in Prenatal Testing, by Region, Through 2028
Table 22 : Global Prenatal Testing Market, by End User, Through 2028
Table 23 : Global Prenatal Testing Market in Diagnostic Laboratories, by Region, Through 2028
Table 24 : Global Prenatal Testing Market in Hospitals, by Region, Through 2028
Table 25 : Global Prenatal Testing Market, by Region, Through 2028
Table 26 : North American Prenatal Testing Market, by Country, Through 2028
Table 27 : European Prenatal Testing Market, by Country, Through 2028
Table 28 : Asia-Pacific Prenatal Testing Market, by Country, Through 2028
Table 29 : Mergers and Acquisitions: Prenatal Testing Manufacturers and Service Providers
Table 30 : Patent Analysis, by Year, 2020-August 2023
Table 31 : Major Patents in Prenatal Testing, by Applicant, 2023-February 2024
Table 32 : ESG Highlights, by Major Players, 2022
Table 33 : ESG Rankings of Major Companies Manufacturing Prenatal Testing, 2023
Table 34 : Abbreviations
Table 35 : Report Sources
Table 36 : 10X Genomics: Company Snapshot
Table 37 : 10X Genomics: Financial Performance, FY 2022 and 2023
Table 38 : 10X Genomics: Product Portfolio
Table 39 : 10X Genomics: News and Key Developments, 2023
Table 40 : Agilent Technologies Inc.: Company Snapshot
Table 41 : Agilent Technologies Inc.: Financial Performance, FY 2022 and 2023
Table 42 : Agilent Technologies Inc.: Product Portfolio
Table 43 : Agilent Technologies Inc.: News and Key Developments, 2020-2023
Table 44 : BGI: Company Snapshot
Table 45 : BGI Genomics: Product Portfolio
Table 46 : BGI Genomics: News and Key Developments, 2023 and 2024
Table 47 : Eurofins Scientific: Company Snapshot
Table 48 : Eurofins Scientific: Financial Performance, FY 2022 and 2023
Table 49 : Eurofins Scientific: Product Portfolio
Table 50 : Eurofins Scientific: News and Key Developments, 2022
Table 51 : F. Hoffmann-La Roche Ltd.: Company Snapshot
Table 52 : F. Hoffmann-La Roche Ltd.: Financial Performance, FY 2022 and 2023
Table 53 : F. Hoffmann-La Roche Ltd.: Product Portfolio
Table 54 : F. Hoffmann-La Roche Ltd.: News and Key Developments, 2022 and 2023
Table 55 : Illumina Inc.: Company Snapshot
Table 56 : Illumina Inc.: Financial Performance, FY 2022 and 2023
Table 57 : Illumina Inc.: Product Portfolio
Table 58 : Illumina Inc.: News and Key Developments, 2022-2024
Table 59 : Laboratory Corporation of America Holdings: Company Snapshot
Table 60 : Laboratory Corporation of America Holdings: Financial Performance, FY 2022 and 2023
Table 61 : Laboratory Corporation of America Holdings: Product Portfolio
Table 62 : Laboratory Corporation of America Holdings: News and Key Developments, 2022-2024
Table 63 : Medicover Genetics: Company Snapshot
Table 64 : Medicover Genetics: Product Portfolio
Table 65 : Medicover Genetics: News and Key Developments, 2022 and 2023
Table 66 : Natera Inc.: Company Snapshot
Table 67 : Natera Inc.: Financial Performance, FY 2021 and 2022
Table 68 : Natera Inc.: Product Portfolio
Table 69 : Natera Inc.: News and Key Developments, 2024
Table 70 : Qiagen: Company Snapshot
Table 71 : QIAGEN: Annual Financials/Revenue, 2021 and 2022
Table 72 : Qiagen: Product Portfolio
Table 73 : Qiagen: News and Key Developments, 2022-2024
Table 74 : Quest Diagnostic Inc.: Company Snapshot
Table 75 : Quest Diagnostic Inc.: Financial Performance, FY 2022 and 2023
Table 76 : Quest Diagnostic Inc.: Product Portfolio
Table 77 : Quest Diagnostic Inc.: News and Key Developments, 2021-2024
Table 78 : Revvity Inc.: Company Snapshot
Table 79 : Revvity Inc.: Financial Performance, FY 2021 and 2022
Table 80 : Revvity Inc.: Product Portfolio
Table 81 : Revvity Inc.: News and Key Developments, 2021-2023
Table 82 : Thermo Fisher Scientific Inc.: Company Snapshot
Table 83 : Thermo Fisher Scientific Inc.: Annual Financials/Revenue, 2021 and 2022
Table 84 : Thermo Fisher Scientific Inc.: Product Portfolio
Table 85 : Thermo Fisher Scientific Inc.: News and Key Developments, 2022 and 2023
Table 86 : Yourgene Health: Company Snapshot
Table 87 : Yourgene Health Product Portfolio
Table 88 : Yourgene Health News/Key Developments, 2022 and 2023

List of Figures

Summary Figure : Global Prenatal Testing Market, by Product, 2020-2028
Figure 1 : Down Syndrome Karyotype
Figure 2 : Market Dynamics: Global Prenatal Testing Market
Figure 3 : Universal NIPT Coverage Across Payer Networks, 2020
Figure 4 : Global Prenatal Testing Market, by Segment Analysis
Figure 5 : Global Prenatal Testing Market, by Product, 2020-2028
Figure 6 : Global Consumables Products Market in Prenatal Testing, by Region, 2020-2028
Figure 7 : Global Instruments Products Market in Prenatal Testing, by Region, 2020-2028
Figure 8 : Global Prenatal Testing Market, by Technology, 2020-2028
Figure 9 : Global Noninvasive Techniques Market in Prenatal Testing, by Type, 2020-2028
Figure 10 : Global Noninvasive Prenatal Testing Market, by Region, 2020-2028
Figure 11 : Global Maternal Serum Screening Market, by Region, 2020-2028
Figure 12 : Global Ultrasound-Based Testing Market, by Region, 2020-2028
Figure 13 : Global Others Noninvasive Techniques Market, by Region, 2020-2028
Figure 14 : Global Invasive Techniques in Prenatal Testing Market, by Type, 2020-2028
Figure 15 : Global Amniocentesis Invasive Techniques Market, by Region, 2020-2028
Figure 16 : Global Chorionic Villus Sampling Invasive Techniques Market, by Region, 2020-2028
Figure 17 : Global Others Invasive Techniques Market, by Region, 2020-2028
Figure 18 : Global Prenatal Testing Market, by Application, 2020-2028
Figure 19 : Global Neural Tube Defects Market in Prenatal Testing, by Region, 2020-2028
Figure 20 : Global Down Syndrome Market in Prenatal Testing, by Region, 2020-2028
Figure 21 : Global Rare Genetic Disorders Market in Prenatal Testing, by Region, 2020-2028
Figure 22 : Global Other Application Market in Prenatal Testing, by Region, 2020-2028
Figure 23 : Global Prenatal Testing Market, by End User, 2020-2028
Figure 24 : Global Prenatal Testing Market in Diagnostic Laboratories, by Region, 2020-2028
Figure 25 : Global Prenatal Testing Market, in Hospitals, by Region, 2020-2028
Figure 26 : Global Prenatal Testing Market, by Region, 2020-2028
Figure 27 : Global Prenatal Testing Market Share, by Region, 2022
Figure 28 : North American Prenatal Testing Market, by Country, 2020-2028
Figure 29 : European Prenatal Testing Market, by Country, 2020-2028
Figure 30 : Asia-Pacific Prenatal Testing Market, by Country, 2020-2028
Figure 31 : Global Prenatal Testing Market Shares, by Key Manufacturers and Service Providers 2022
Figure 32 : Published Patent Share, by Country, 2020-2023
Figure 33 : Business Benefits of a Strong ESG Proposition
Figure 34 : ESG-Adoption Level Across All the Industries, 2021 and 2022
Figure 35 : 10 Business Sustainability Trends Identified for 2023
Figure 36 : 10X Genomics: Revenue Share, by Business Unit, FY 2023
Figure 37 : 10X Genomics: Revenue Share, by Country/Region, FY 2023
Figure 38 : Agilent Technologies Inc.: Revenue Share, by Business Unit, FY 2023
Figure 39 : Agilent Technologies Inc.: Revenue Share, by Country/Region, FY 2023
Figure 40 : Eurofins Scientific: Revenue Share, by Country/Region, FY 2023
Figure 41 : F. Hoffmann-La Roche Ltd.: Revenue Share, by Business Unit, FY 2023
Figure 42 : F. Hoffmann-La Roche Ltd.: Revenue Share, by Country/Region, FY 2023
Figure 43 : Illumina Inc.: Revenue Share, by Business Unit, FY 2022
Figure 44 : Illumina Inc.: Revenue Share, by Country/Region, FY 2023
Figure 45 : Laboratory Corporation of America Holdings: Revenue Share, by Business Unit, FY 2023
Figure 46 : Laboratory Corporation of America Holdings: Revenue Share, by Country/Region, FY 2023
Figure 47 : Natera Inc.: Revenue Share, by Business Unit, FY 2022
Figure 48 : Natera Inc.: Revenue Share, by Country/Region, FY 2022
Figure 49 : Qiagen: Revenue Share, by Business Unit, 2022
Figure 50 : Qiagen: Revenue Share, by Region, 2022
Figure 51 : Quest Diagnostic Inc.: Revenue Share, by Business Unit, FY 2023
Figure 52 : Revvity Inc.: Revenue Share, by Business Unit, FY 2022
Figure 53 : Revvity Inc.: Revenue Share, by Country/Region, FY 2022
Figure 54 : Thermo Fisher Scientific Inc.: Revenue Share, by Business Unit, 2022
Figure 55 : Thermo Fisher Scientific Inc.: Revenue Share, by Region, 2022